miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes

Xiang Zhong(Gansu University of Traditional Chinese Medicine), Hui Y. Lan(Zhejiang Pharmaceutical College)
Diabetologia
January 4, 2013
Cited by 353


Related Papers